調査レポート | • レポートコード：QYR2104Z1633 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、新型コロナウイルス感染症ワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（DNA、非複製ウイルスベクター、タンパク質サブユニット、RNA、その他）、用途別市場規模（成人、子供）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症ワクチンの市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症ワクチンの種類別市場規模（DNA、非複製ウイルスベクター、タンパク質サブユニット、RNA、その他） ・新型コロナウイルス感染症ワクチンの用途別市場規模（成人、子供） ・新型コロナウイルス感染症ワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症ワクチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症ワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症ワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症ワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Moderna、CanSino Biologicals、Inovio Pharmaceuticals、Shenzhen Geno-Immune Medical Institute、GlaxoSmithKine、Pfizer、Johnson＆Johnson、Heat Biologics、Sanofi） ・結論 |
A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.
North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.
Market Analysis and Insights: Global Covid-19 Vaccine Market
The global Covid-19 Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Vaccine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Vaccine market.
Global Covid-19 Vaccine Scope and Market Size
Covid-19 Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Covid-19 Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
The classification of COVID-19 Vaccine includes Non-replicating Viral Vector, Protein Subunit, DNA, RNA, Other.The proportion of RNA in 2026 is about 43%.
Segment by Application
Adults
Children
The classification of COVID-19 Vaccine includes Non-replicating Viral Vector, Protein Subunit, DNA, RNA, Other the proportion of RNA in 2026 is about 43%.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Vaccine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Vaccine Market Perspective (2016-2027)
2.2 Covid-19 Vaccine Growth Trends by Regions
2.2.1 Covid-19 Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Covid-19 Vaccine Historic Market Share by Regions (2016-2021)
2.2.3 Covid-19 Vaccine Forecasted Market Size by Regions (2022-2027)
2.3 Covid-19 Vaccine Industry Dynamic
2.3.1 Covid-19 Vaccine Market Trends
2.3.2 Covid-19 Vaccine Market Drivers
2.3.3 Covid-19 Vaccine Market Challenges
2.3.4 Covid-19 Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Vaccine Players by Revenue
3.1.1 Global Top Covid-19 Vaccine Players by Revenue (2016-2021)
3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2016-2021)
3.2 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Vaccine Revenue
3.4 Global Covid-19 Vaccine Market Concentration Ratio
3.4.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2020
3.5 Covid-19 Vaccine Key Players Head office and Area Served
3.6 Key Players Covid-19 Vaccine Product Solution and Service
3.7 Date of Enter into Covid-19 Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Vaccine Breakdown Data by Type
4.1 Global Covid-19 Vaccine Historic Market Size by Type (2016-2021)
4.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2022-2027)
5 Covid-19 Vaccine Breakdown Data by Application
5.1 Global Covid-19 Vaccine Historic Market Size by Application (2016-2021)
5.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Covid-19 Vaccine Market Size (2016-2027)
6.2 North America Covid-19 Vaccine Market Size by Type
6.2.1 North America Covid-19 Vaccine Market Size by Type (2016-2021)
6.2.2 North America Covid-19 Vaccine Market Size by Type (2022-2027)
6.2.3 North America Covid-19 Vaccine Market Size by Type (2016-2027)
6.3 North America Covid-19 Vaccine Market Size by Application
6.3.1 North America Covid-19 Vaccine Market Size by Application (2016-2021)
6.3.2 North America Covid-19 Vaccine Market Size by Application (2022-2027)
6.3.3 North America Covid-19 Vaccine Market Size by Application (2016-2027)
6.4 North America Covid-19 Vaccine Market Size by Country
6.4.1 North America Covid-19 Vaccine Market Size by Country (2016-2021)
6.4.2 North America Covid-19 Vaccine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Covid-19 Vaccine Market Size (2016-2027)
7.2 Europe Covid-19 Vaccine Market Size by Type
7.2.1 Europe Covid-19 Vaccine Market Size by Type (2016-2021)
7.2.2 Europe Covid-19 Vaccine Market Size by Type (2022-2027)
7.2.3 Europe Covid-19 Vaccine Market Size by Type (2016-2027)
7.3 Europe Covid-19 Vaccine Market Size by Application
7.3.1 Europe Covid-19 Vaccine Market Size by Application (2016-2021)
7.3.2 Europe Covid-19 Vaccine Market Size by Application (2022-2027)
7.3.3 Europe Covid-19 Vaccine Market Size by Application (2016-2027)
7.4 Europe Covid-19 Vaccine Market Size by Country
7.4.1 Europe Covid-19 Vaccine Market Size by Country (2016-2021)
7.4.2 Europe Covid-19 Vaccine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Vaccine Market Size (2016-2027)
8.2 Asia-Pacific Covid-19 Vaccine Market Size by Type
8.2.1 Asia-Pacific Covid-19 Vaccine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Covid-19 Vaccine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Covid-19 Vaccine Market Size by Type (2016-2027)
8.3 Asia-Pacific Covid-19 Vaccine Market Size by Application
8.3.1 Asia-Pacific Covid-19 Vaccine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Covid-19 Vaccine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Covid-19 Vaccine Market Size by Application (2016-2027)
8.4 Asia-Pacific Covid-19 Vaccine Market Size by Region
8.4.1 Asia-Pacific Covid-19 Vaccine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Covid-19 Vaccine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Covid-19 Vaccine Market Size (2016-2027)
9.2 Latin America Covid-19 Vaccine Market Size by Type
9.2.1 Latin America Covid-19 Vaccine Market Size by Type (2016-2021)
9.2.2 Latin America Covid-19 Vaccine Market Size by Type (2022-2027)
9.2.3 Latin America Covid-19 Vaccine Market Size by Type (2016-2027)
9.3 Latin America Covid-19 Vaccine Market Size by Application
9.3.1 Latin America Covid-19 Vaccine Market Size by Application (2016-2021)
9.3.2 Latin America Covid-19 Vaccine Market Size by Application (2022-2027)
9.3.3 Latin America Covid-19 Vaccine Market Size by Application (2016-2027)
9.4 Latin America Covid-19 Vaccine Market Size by Country
9.4.1 Latin America Covid-19 Vaccine Market Size by Country (2016-2021)
9.4.2 Latin America Covid-19 Vaccine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Vaccine Market Size (2016-2027)
10.2 Middle East & Africa Covid-19 Vaccine Market Size by Type
10.2.1 Middle East & Africa Covid-19 Vaccine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Covid-19 Vaccine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Covid-19 Vaccine Market Size by Type (2016-2027)
10.3 Middle East & Africa Covid-19 Vaccine Market Size by Application
10.3.1 Middle East & Africa Covid-19 Vaccine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Covid-19 Vaccine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Covid-19 Vaccine Market Size by Application (2016-2027)
10.4 Middle East & Africa Covid-19 Vaccine Market Size by Country
10.4.1 Middle East & Africa Covid-19 Vaccine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Covid-19 Vaccine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Moderna
11.1.1 Moderna Company Details
11.1.2 Moderna Business Overview
11.1.3 Moderna Covid-19 Vaccine Introduction
11.1.4 Moderna Revenue in Covid-19 Vaccine Business (2016-2021)
11.1.5 Moderna Recent Development
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Company Details
11.2.2 CanSino Biologicals Business Overview
11.2.3 CanSino Biologicals Covid-19 Vaccine Introduction
11.2.4 CanSino Biologicals Revenue in Covid-19 Vaccine Business (2016-2021)
11.2.5 CanSino Biologicals Recent Development
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Details
11.3.2 Inovio Pharmaceuticals Business Overview
11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
11.3.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2016-2021)
11.3.5 Inovio Pharmaceuticals Recent Development
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Company Details
11.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction
11.4.4 Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2016-2021)
11.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Company Details
11.5.2 GlaxoSmithKine Business Overview
11.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction
11.5.4 GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2016-2021)
11.5.5 GlaxoSmithKine Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Covid-19 Vaccine Introduction
11.6.4 Pfizer Revenue in Covid-19 Vaccine Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Company Details
11.7.2 Johnson＆Johnson Business Overview
11.7.3 Johnson＆Johnson Covid-19 Vaccine Introduction
11.7.4 Johnson＆Johnson Revenue in Covid-19 Vaccine Business (2016-2021)
11.7.5 Johnson＆Johnson Recent Development
11.8 Heat Biologics
11.8.1 Heat Biologics Company Details
11.8.2 Heat Biologics Business Overview
11.8.3 Heat Biologics Covid-19 Vaccine Introduction
11.8.4 Heat Biologics Revenue in Covid-19 Vaccine Business (2016-2021)
11.8.5 Heat Biologics Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Covid-19 Vaccine Introduction
11.9.4 Sanofi Revenue in Covid-19 Vaccine Business (2016-2021)
11.9.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Covid-19 Vaccine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DNA
Table 3. Key Players of Non-replicating Viral Vector
Table 4. Key Players of Protein Subunit
Table 5. Key Players of RNA
Table 6. Key Players of Others
Table 7. Global Covid-19 Vaccine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Covid-19 Vaccine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Covid-19 Vaccine Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Covid-19 Vaccine Market Share by Regions (2016-2021)
Table 11. Global Covid-19 Vaccine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Covid-19 Vaccine Market Share by Regions (2022-2027)
Table 13. Covid-19 Vaccine Market Trends
Table 14. Covid-19 Vaccine Market Drivers
Table 15. Covid-19 Vaccine Market Challenges
Table 16. Covid-19 Vaccine Market Restraints
Table 17. Global Covid-19 Vaccine Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Covid-19 Vaccine Market Share by Players (2016-2021)
Table 19. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Vaccine as of 2020)
Table 20. Ranking of Global Top Covid-19 Vaccine Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Covid-19 Vaccine Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Covid-19 Vaccine Product Solution and Service
Table 24. Date of Enter into Covid-19 Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Covid-19 Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Covid-19 Vaccine Revenue Market Share by Type (2016-2021)
Table 28. Global Covid-19 Vaccine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Covid-19 Vaccine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Covid-19 Vaccine Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Covid-19 Vaccine Revenue Market Share by Application (2016-2021)
Table 32. Global Covid-19 Vaccine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Covid-19 Vaccine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Covid-19 Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Covid-19 Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Covid-19 Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Covid-19 Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Covid-19 Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Covid-19 Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Covid-19 Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Covid-19 Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Covid-19 Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Covid-19 Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Covid-19 Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Covid-19 Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Covid-19 Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Covid-19 Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Covid-19 Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Covid-19 Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Covid-19 Vaccine Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Covid-19 Vaccine Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Covid-19 Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Covid-19 Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Covid-19 Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Covid-19 Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Covid-19 Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Covid-19 Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Covid-19 Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Covid-19 Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Covid-19 Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Covid-19 Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Covid-19 Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Covid-19 Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 64. Moderna Company Details
Table 65. Moderna Business Overview
Table 66. Moderna Covid-19 Vaccine Product
Table 67. Moderna Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 68. Moderna Recent Development
Table 69. CanSino Biologicals Company Details
Table 70. CanSino Biologicals Business Overview
Table 71. CanSino Biologicals Covid-19 Vaccine Product
Table 72. CanSino Biologicals Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 73. CanSino Biologicals Recent Development
Table 74. Inovio Pharmaceuticals Company Details
Table 75. Inovio Pharmaceuticals Business Overview
Table 76. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 77. Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 78. Inovio Pharmaceuticals Recent Development
Table 79. Shenzhen Geno-Immune Medical Institute Company Details
Table 80. Shenzhen Geno-Immune Medical Institute Business Overview
Table 81. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 82. Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 83. Shenzhen Geno-Immune Medical Institute Recent Development
Table 84. GlaxoSmithKine Company Details
Table 85. GlaxoSmithKine Business Overview
Table 86. GlaxoSmithKine Covid-19 Vaccine Product
Table 87. GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 88. GlaxoSmithKine Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Covid-19 Vaccine Product
Table 92. Pfizer Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Johnson＆Johnson Company Details
Table 95. Johnson＆Johnson Business Overview
Table 96. Johnson＆Johnson Covid-19 Vaccine Product
Table 97. Johnson＆Johnson Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 98. Johnson＆Johnson Recent Development
Table 99. Heat Biologics Company Details
Table 100. Heat Biologics Business Overview
Table 101. Heat Biologics Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 102. Heat Biologics Recent Development
Table 103. Sanofi Company Details
Table 104. Sanofi Business Overview
Table 105. Sanofi Covid-19 Vaccine Product
Table 106. Sanofi Revenue in Covid-19 Vaccine Business (2016-2021) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Vaccine Market Share by Type: 2020 VS 2027
Figure 2. DNA Features
Figure 3. Non-replicating Viral Vector Features
Figure 4. Protein Subunit Features
Figure 5. RNA Features
Figure 6. Others Features
Figure 7. Global Covid-19 Vaccine Market Share by Application: 2020 VS 2027
Figure 8. Adults Case Studies
Figure 9. Children Case Studies
Figure 10. Covid-19 Vaccine Report Years Considered
Figure 11. Global Covid-19 Vaccine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Covid-19 Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Covid-19 Vaccine Market Share by Regions: 2020 VS 2027
Figure 14. Global Covid-19 Vaccine Market Share by Regions (2022-2027)
Figure 15. Global Covid-19 Vaccine Market Share by Players in 2020
Figure 16. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Vaccine as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2020
Figure 18. Global Covid-19 Vaccine Revenue Market Share by Type (2016-2021)
Figure 19. Global Covid-19 Vaccine Revenue Market Share by Type (2022-2027)
Figure 20. North America Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Covid-19 Vaccine Market Share by Type (2016-2027)
Figure 22. North America Covid-19 Vaccine Market Share by Application (2016-2027)
Figure 23. North America Covid-19 Vaccine Market Share by Country (2016-2027)
Figure 24. United States Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Covid-19 Vaccine Market Share by Type (2016-2027)
Figure 28. Europe Covid-19 Vaccine Market Share by Application (2016-2027)
Figure 29. Europe Covid-19 Vaccine Market Share by Country (2016-2027)
Figure 30. Germany Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Covid-19 Vaccine Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Covid-19 Vaccine Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Covid-19 Vaccine Market Share by Region (2016-2027)
Figure 40. China Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Covid-19 Vaccine Market Share by Type (2016-2027)
Figure 48. Latin America Covid-19 Vaccine Market Share by Application (2016-2027)
Figure 49. Latin America Covid-19 Vaccine Market Share by Country (2016-2027)
Figure 50. Mexico Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Covid-19 Vaccine Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Covid-19 Vaccine Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Covid-19 Vaccine Market Share by Country (2016-2027)
Figure 56. Turkey Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Covid-19 Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Moderna Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 60. CanSino Biologicals Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 61. Inovio Pharmaceuticals Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 62. Shenzhen Geno-Immune Medical Institute Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 63. GlaxoSmithKine Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 65. Johnson＆Johnson Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 66. Heat Biologics Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Covid-19 Vaccine Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の新型コロナウイルス感染症組換えタンパク質ワクチン市場規模・現状・予測（2021年-2027年） Preparation and immunogenicity and immunoprotection of Hib polysaccharide conjugate vaccine based on pneumococcal surface adhesive (PsaA).Methods PsaA gene recombinant protein (rPsaA) was prepared by genetic engineering, and then conjugated with Hib polysaccharide by amide condensation.The 3-week-ol…- 世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…
- 世界の新型コロナウイルス感染症DNAワクチン市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 DNA Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 DNA Vaccine status, future forecast, growth opportunity, key market, and key play…
- 世界の遺伝子組み換えサブユニットワクチン市場規模・現状・予測（2021年-2027年） A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a gene product—protein or polypeptide. Market Analysis and Insights: Global Gene Engineered Subunit Vaccine Market…
- 世界のアデノウイルスベクターワクチン市場規模・現状・予測（2021年-2027年） Adenovirus vector vaccine refers to the adenovirus as the carrier, the protective antigen gene is recombinant into the adenovirus genome, using the recombinant adenovirus can express the protective antigen gene made of vaccine.The characteristics of adenovirus vector vaccine showed that the adenovir…